From the source
From the source
Raises $600M in first external funding round led by Thrive Capital
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and follow-on capital from Alphabet.
The company aims to apply its AI drug design engine to accelerate drug discovery across multiple therapeutic areas.
From the source
Isomorphic Labs announces it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing investor, Alphabet.
isomorphiclabs.com
